Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Aesthetic Injectables Pipeline Market Report Overview

Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. The Aesthetic Injectables pipeline market research report provides comprehensive information about the aesthetic Injectables pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Hyaluronic Acid Fillers

·       Non-Hyaluronic Acid Fillers

·       Biphasic Hyaluronic Acid Fillers

·       Poly-L-Lactic Acid (PLLA) Fillers

Key Territories ·       United States

·       Europe

·       China

·       South Korea

·       Others

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       NIFDS

·       510(k)

·       BOPA

·       HSA

·       MDITAC

·       MDL

·       MDCO

·       ANVISA

·       ICAC

·       MDA

·       Ninsho

·       TGA

·       Shonin

Leading Companies ·       AbbVie Inc

·       BioPlus Co Ltd

·       Celltrix AB

·       Galderma SA

·       Others

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Aesthetic Injectables Pipeline Market Segments

Some of the key segments in the aesthetic Injectables pipeline market are Hyaluronic Acid Fillers, Non-Hyaluronic Acid Fillers, Biphasic Hyaluronic Acid Fillers, and Poly-L-Lactic Acid (PLLA) Fillers. As of May 2023, Hyaluronic Acid Fillers had the highest share.

Aesthetic Injectables Pipeline Market Analysis, by Segments, 2023 (%)

Aesthetic Injectables Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the aesthetic Injectables pipeline market, download a free report sample

Aesthetic Injectables Pipeline Market Segmentation by Territories

Some key territories with aesthetic Injectables products in the pipeline are the US, Europe, China, South Korea, Israel, and Taiwan among others. As of May 2023, the US had the highest number of products in the pipeline compared to the other territories.

Aesthetic Injectables Pipeline Market Analysis, by Territories, 2023 (%)

Aesthetic Injectables Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the aesthetic Injectables pipeline market, download a free report sample

Aesthetic Injectables Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths followed by the aesthetic Injectables pipeline products are PMA, CE, NMPA, NIFDS, 510 (k), BOPA, HAS, MDITAC, and MDL among others.  As of May 2023, the mostly deployed regulatory path for aesthetic Injectables market was PMA.

Aesthetic Injectables Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Aesthetic Injectables Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the Aesthetic Injectables pipeline market, download a free report sample

Aesthetic Injectables Pipeline Market – Competitive Landscape

Some of the leading companies in the Aesthetic Injectables pipeline reconstruction market are AbbVie Inc, BioPlus Co Ltd, Celltrix AB, Galderma SA, Genzyme Corp, Medytox Inc, Teoxane SA, and Tissueform Inc among others.

AbbVie Inc Overview: AbbVie Inc (AbbVie) is a specialty biopharmaceutical company, which discovers, develops, manufactures, and commercializes drugs for the treatment of chronic and complex diseases. Its drugs are indicated for the treatment of metabolic and rheumatological diseases, neurological disorders, skin diseases, rheumatoid arthritis, pain related to endometriosis, pediatric Crohn’s disease, cancer, and other serious health conditions. AbbVie is also advancing its pipeline programs for the treatment of Crohn’s disease, Parkinson’s disease, viral diseases, wet AMD, various cancers, neurological disorders, aesthetics, and other autoimmune diseases. The company markets its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses worldwide. AbbVie is headquartered in North Chicago, Illinois, the US.

Segments Covered in the Report

Aesthetic Injectables Pipeline Market Segments Outlook

  • Hyaluronic Acid Fillers
  • Non-Hyaluronic Acid Fillers
  • Biphasic Hyaluronic Acid Fillers
  • Poly-L-Lactic Acid (PLLA) Fillers

Aesthetic Injectables Pipeline Market Territories Outlook

  • United States
  • Europe
  • China
  • South Korea
  • Global
  • Israel
  • Taiwan
  • Singapore
  • Vietnam
  • Canada
  • Japan
  • Hong Kong
  • Australia
  • Brazil
  • India
  • Malaysia
  • New Zealand
  • Philippines
  • Russia
  • Germany
  • Mexico
  • Indonesia
  • Egypt
  • Turkey

Aesthetic Injectables Pipeline Market Regulatory Paths Outlook

  • PMA
  • CE
  • NMPA
  • NIFDS
  • 510(k)
  • BOPA
  • HSA
  • MDITAC
  • MDL
  • MDCO
  • ANVISA
  • ICAC
  • MDA
  • Ninsho
  • TGA
  • Shonin

Scope

  • Extensive coverage of the Aesthetic Injectables under development
  • Reviews details of major pipeline reconstruction which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
  • The coverage of pipeline reconstruction based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Aesthetic Injectables under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

AbbVie Inc
Acro Biomedical Co Ltd
Advanced Aesthetic Technologies Inc
Aeon Astron Corporation
Aesthetic Medical Device
Allergan Aesthetics
Almirall Ltd
Beijing MeiYan KongJian Technology Co Ltd
BioPlus Co Ltd
Bioxis Pharmaceuticals
BMG Pharma SpA
Bmi Korea Co Ltd
CellPraxis
Celltrix AB
Collplant Biotechnologies Ltd
Dexlevo Inc
Dongkook Pharmaceutical Co Ltd
EternoGen Aesthetics LLC
Fillmed Laboratoires
G2GBIO Inc
Galderma SA
Genzyme Corp
Hallura Ltd
Histogen Inc
Hugel Inc
Innovia LLC
inSoma Bio Inc
Inventage Lab Inc
Jinwoo Bio Co Ltd
Juvenis Ltd
Khorionyx SA
Laboratoires Vivacy SAS
LG Chem Ltd
LifeSprout Inc
Medytox Inc
Merz North America Inc
Mesoestetic Pharma Group SL
Moma Therapeutics Inc
N8 Medical LLC
Oligo Medic Inc
PB&B SA
Peptron Inc
PetVivo Holdings Inc
Q-Med AB
RepliCel Life Sciences Inc
Samyang Biopharmaceuticals Corp
Sebana Medical Ltd
Shanghai Haohai Biological Technology Co Ltd
Shin Poong Pharm Co Ltd
Silk Medical Aesthetics Inc
Sinclair Pharma Ltd
Sofregen Medical Inc
SunMax Biotechnology Co Ltd
TEI Biosciences Inc
Tempo Therapeutics Inc
Teoxane SA
Tetratherix Pty Ltd
Tissueform Inc
University of California Santa Barbara
University of Missouri

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 13

2 Introduction 14

2.1 Aesthetic Injectables Overview 14

3 Products under Development 15

3.1 Aesthetic Injectables – Pipeline Products by Stage of Development 15

3.2 Aesthetic Injectables – Pipeline Products by Segment 16

3.3 Aesthetic Injectables – Pipeline Products by Territory 17

3.4 Aesthetic Injectables – Pipeline Products by Regulatory Path 19

3.5 Aesthetic Injectables – Pipeline Products by Estimated Approval Date 20

3.6 Aesthetic Injectables – Ongoing Clinical Trials 21

4 Aesthetic Injectables – Pipeline Products under Development by Companies 22

4.1 Aesthetic Injectables Companies – Pipeline Products by Stage of Development 22

4.2 Aesthetic Injectables – Pipeline Products by Stage of Development 25

5 Aesthetic Injectables Companies and Product Overview 28

5.1 AbbVie Inc Company Overview 28

5.1.1 AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.2 Acro Biomedical Co Ltd Company Overview 29

5.2.1 Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

5.3 Advanced Aesthetic Technologies Inc Company Overview 30

5.3.1 Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 30

5.4 Aeon Astron Corporation Company Overview 35

5.4.1 Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 35

5.5 Aesthetic Medical Device Company Overview 36

5.5.1 Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 36

5.6 Allergan Aesthetics Company Overview 39

5.6.1 Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 39

5.7 Almirall Ltd Company Overview 51

5.7.1 Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.8 Beijing MeiYan KongJian Technology Co Ltd Company Overview 52

5.8.1 Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.9 BioPlus Co Ltd Company Overview 55

5.9.1 BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

5.10 Bioxis Pharmaceuticals Company Overview 58

5.10.1 Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 58

5.11 BMG Pharma SpA Company Overview 61

5.11.1 BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 61

5.12 Bmi Korea Co Ltd Company Overview 63

5.12.1 Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

5.13 CellPraxis Company Overview 64

5.13.1 CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 64

5.14 Celltrix AB Company Overview 65

5.14.1 Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 65

5.15 Collplant Biotechnologies Ltd Company Overview 66

5.15.1 Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.16 Dexlevo Inc Company Overview 68

5.16.1 Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.17 Dongkook Pharmaceutical Co Ltd Company Overview 69

5.17.1 Dongkook Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

5.18 EternoGen Aesthetics LLC Company Overview 72

5.18.1 EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 72

5.19 Fillmed Laboratoires Company Overview 73

5.19.1 Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 73

5.20 G2GBIO Inc Company Overview 75

5.20.1 G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.21 Galderma SA Company Overview 76

5.21.1 Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 76

5.22 Genzyme Corp Company Overview 77

5.22.1 Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 77

5.23 Hallura Ltd Company Overview 78

5.23.1 Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

5.24 Histogen Inc Company Overview 80

5.24.1 Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 80

5.25 Hugel Inc Company Overview 81

5.25.1 Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 81

5.26 Innovia LLC Company Overview 85

5.26.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.27 inSoma Bio Inc Company Overview 86

5.27.1 inSoma Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.28 Inventage Lab Inc Company Overview 87

5.28.1 Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 87

5.29 Jinwoo Bio Co Ltd Company Overview 90

5.29.1 Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.30 Juvenis Ltd Company Overview 93

5.30.1 Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.31 Khorionyx SA Company Overview 94

5.31.1 Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 94

5.32 Laboratoires Vivacy SAS Company Overview 95

5.32.1 Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview 95

5.33 LG Chem Ltd Company Overview 98

5.33.1 LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.34 LifeSprout Inc Company Overview 107

5.34.1 LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 107

5.35 Medytox Inc Company Overview 110

5.35.1 Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 110

5.36 Merz North America Inc Company Overview 113

5.36.1 Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 113

5.37 Mesoestetic Pharma Group SL Company Overview 116

5.37.1 Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 116

5.38 Moma Therapeutics Inc Company Overview 120

5.38.1 Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.39 N8 Medical LLC Company Overview 121

5.39.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 121

5.40 Oligo Medic Inc Company Overview 122

5.40.1 Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 122

5.41 PB&B SA Company Overview 123

5.41.1 PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 123

5.42 Peptron Inc Company Overview 124

5.42.1 Peptron Inc Pipeline Products & Ongoing Clinical Trials Overview 124

5.43 PetVivo Holdings Inc Company Overview 125

5.43.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 125

5.44 Q-Med AB Company Overview 127

5.44.1 Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 127

5.45 RepliCel Life Sciences Inc Company Overview 132

5.45.1 RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 132

5.46 Samyang Biopharmaceuticals Corp Company Overview 133

5.46.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 133

5.47 Sebana Medical Ltd Company Overview 135

5.47.1 Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

5.48 Shanghai Haohai Biological Technology Co Ltd Company Overview 136

5.48.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

5.49 Shin Poong Pharm Co Ltd Company Overview 138

5.49.1 Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 138

5.50 Silk Medical Aesthetics Inc Company Overview 139

5.50.1 Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 139

5.51 Sinclair Pharma Ltd Company Overview 143

5.51.1 Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 143

5.52 Sofregen Medical Inc Company Overview 147

5.52.1 Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.53 SunMax Biotechnology Co Ltd Company Overview 150

5.53.1 SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 150

5.54 TEI Biosciences Inc Company Overview 155

5.54.1 TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 155

5.55 Tempo Therapeutics Inc Company Overview 156

5.55.1 Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 156

5.56 Teoxane SA Company Overview 157

5.56.1 Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 157

5.57 Tetratherix Pty Ltd Company Overview 161

5.57.1 Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

5.58 Tissueform Inc Company Overview 162

5.58.1 Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 162

5.59 University of California Santa Barbara Company Overview 163

5.59.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 163

5.60 University of Missouri Company Overview 164

5.60.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 164

6 Aesthetic Injectables- Recent Developments 165

6.1 Dec 16, 2022: MOXI and BBL treatments are now available at Chapin Aesthetics 165

7 Appendix 166

7.1 Methodology 166

7.2 About GlobalData 169

7.3 Contact Us 169

7.4 Disclaimer 169

Table

Aesthetic Injectables – Pipeline Products by Stage of Development 15

Aesthetic Injectables – Pipeline Products by Segment 16

Aesthetic Injectables – Pipeline Products by Territory 17

Aesthetic Injectables – Pipeline Products by Regulatory Path 19

Aesthetic Injectables – Pipeline Products by Estimated Approval Date 20

Aesthetic Injectables – Ongoing Clinical Trials 21

Aesthetic Injectables Companies – Pipeline Products by Stage of Development 22

Aesthetic Injectables – Pipeline Products by Stage of Development 25

AbbVie Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Hyaluronic Acid Filler – Skin – Product Status 28

Hyaluronic Acid Filler – Skin – Product Description 28

Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

ACROFILL – Product Status 29

ACROFILL – Product Description 29

Advanced Aesthetic Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 30

Algeness DF – Product Status 30

Algeness DF – Product Description 30

Algeness HD – Product Status 31

Algeness HD – Product Description 31

Algeness LD – Product Status 31

Algeness LD – Product Description 32

Algeness VL – Product Status 32

Algeness VL – Product Description 32

Advanced Aesthetic Technologies Inc – Ongoing Clinical Trials Overview 33

Algeness VL – A Pivotal Clinical Study to Evaluate the Effectiveness and Safety of Algeness VL for the Correction of Moderate to Severe Nasolabial Folds 34

Algeness VL – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 34

Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 35

BioDermal Filler – Product Status 35

BioDermal Filler – Product Description 35

Aesthetic Medical Device Pipeline Products & Ongoing Clinical Trials Overview 36

Alluris – Product Status 36

Alluris – Product Description 36

Skinlumina – Product Status 37

Skinlumina – Product Description 37

SkinTechMD – Product Status 37

SkinTechMD – Product Description 38

Allergan Aesthetics Pipeline Products & Ongoing Clinical Trials Overview 39

AAM SubQ Body Filler – Product Status 39

AAM SubQ Body Filler – Product Description 40

ADM Subdermal Body Filler – Product Status 40

ADM Subdermal Body Filler – Product Description 40

Elastagen – Acne Scars – Product Status 40

Elastagen – Acne Scars – Product Description 41

Elastagen – Skin Quality – Product Status 41

Elastagen – Skin Quality – Product Description 41

HA Threads – Product Status 41

HA Threads – Product Description 42

Juvederm – Decolletage – Product Status 42

Juvederm – Decolletage – Product Description 42

Juvederm – Hands – Product Status 42

Juvederm – Hands – Product Description 43

Juvederm – Neck Lines – Product Status 43

Juvederm – Neck Lines – Product Description 43

Juvederm RejuveCross – Deep Wrinkles – Product Status 43

Juvederm RejuveCross – Deep Wrinkles – Product Description 44

Juvederm RejuveCross – Etched Lines Wrinkles – Product Status 44

Juvederm RejuveCross – Etched Lines Wrinkles – Product Description 44

Juvederm RejuveCross Volumize – Cheek Augmentation – Product Status 44

Juvederm RejuveCross Volumize – Cheek Augmentation – Product Description 45

Juvederm Voluma – Nose – Product Status 45

Juvederm Voluma – Nose – Product Description 45

Juvederm Voluma – Temple – Product Status 45

Juvederm Voluma – Temple – Product Description 46

Juvederm Voluma Global – Malar Augmentation – Product Status 46

Juvederm Voluma Global – Malar Augmentation – Product Description 46

rhCollagen Dermal Filler – Product Status 46

rhCollagen Dermal Filler – Product Description 47

Allergan Aesthetics – Ongoing Clinical Trials Overview 48

Juvederm Voluma Global – Malar Augmentation – A Prospective, Multi-center, Randomized, Controlled, Single-blind Study of the Safety and Effectiveness of Algeness DF 3.5% Deep Volumizing Filler to Correct Age-related Volume Deficit in the Mid-face 49

Juvederm Voluma Global – Malar Augmentation – Clinical, Instrumental and Histological Evaluation of the Combined Use of Onabotulinumtoxin A and Hyaluronic Acid Fillers in Patients with Facial Paralysis 49

Juvederm Voluma – Temple – A Multicenter, Evaluator-blinded, Randomized, No-treatment Controlled Study to Evaluate the Safety and Effectiveness of Juvederm Voluma with Lidocaine for Correction of Temple Hollowing in Chinese Population 50

Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

Hyaluronic Acid Facial Filler – Product Status 51

Hyaluronic Acid Facial Filler – Product Description 51

Beijing MeiYan KongJian Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

Complex Collagen Filler (Type III) – Product Status 52

Complex Collagen Filler (Type III) – Product Description 52

First Generation PLLA Filler (Type III) – Product Status 53

First Generation PLLA Filler (Type III) – Product Description 53

Second Generation PCL Filler (Type III) – Product Status 53

Second Generation PCL Filler (Type III) – Product Description 54

BioPlus Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 55

Biological Breast – Product Status 55

Biological Breast – Product Description 55

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Status 56

Hyaluronic Acid Filler – Bio-cartilage Replacement – Product Description 56

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Status 56

Hyaluronic Acid Filler – Bladder Tissue Repair – Product Description 57

Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview 58

Cytosmile – Product Status 58

Cytosmile – Product Description 58

MTI-12 – Product Status 59

MTI-12 – Product Description 59

MTI-12 – Surgical Repair – Product Status 59

MTI-12 – Surgical Repair – Product Description 60

BMG Pharma SpA Pipeline Products & Ongoing Clinical Trials Overview 61

SGA300 – Product Status 61

SGA300 – Product Description 61

SGA302 – Product Status 62

SGA302 – Product Description 62

Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 63

BMI4002 – Product Status 63

BMI4002 – Product Description 63

CellPraxis Pipeline Products & Ongoing Clinical Trials Overview 64

Lipage – Product Status 64

Lipage – Product Description 64

Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview 65

Credurance – Product Status 65

Credurance – Product Description 65

Collplant Biotechnologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

rhCollagen Based Photocurable Regenerative Dermal Filler – Product Status 66

rhCollagen Based Photocurable Regenerative Dermal Filler – Product Description 66

rhCollagen Based Soft Tissue Filler – Product Status 67

rhCollagen Based Soft Tissue Filler – Product Description 67

Dexlevo Inc Pipeline Products & Ongoing Clinical Trials Overview 68

Gouri – Product Status 68

Gouri – Product Description 68

Dongkook Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

DKB-119 – Product Status 69

DKB-119 – Product Description 69

DKB-133 – Product Status 70

DKB-133 – Product Description 70

DKM-410 – Product Status 70

DKM-410 – Product Description 71

DKM-423 – Product Status 71

DKM-423 – Product Description 71

EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview 72

Cellifique – Product Status 72

Cellifique – Product Description 72

Fillmed Laboratoires Pipeline Products & Ongoing Clinical Trials Overview 73

NCTF 135 – Product Status 73

NCTF 135 – Product Description 73

NCTF 135 HA – Product Status 74

NCTF 135 HA – Product Description 74

G2GBIO Inc Pipeline Products & Ongoing Clinical Trials Overview 75

GB-3001 – Product Status 75

GB-3001 – Product Description 75

Galderma SA Pipeline Products & Ongoing Clinical Trials Overview 76

Biostimulator Filler – Product Status 76

Biostimulator Filler – Product Description 76

Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview 77

Prevelle Lift – Product Status 77

Prevelle Lift – Product Description 77

Hallura Ltd Pipeline Products & Ongoing Clinical Trials Overview 78

BiOLinkMatrix Gel – Product Status 78

BiOLinkMatrix Gel – Product Description 78

Hyaluronic Acid Dermal Filler – Product Status 79

Hyaluronic Acid Dermal Filler – Product Description 79

Histogen Inc Pipeline Products & Ongoing Clinical Trials Overview 80

HST002 – Product Status 80

HST002 – Product Description 80

Hugel Inc Pipeline Products & Ongoing Clinical Trials Overview 81

The Chaeum Pure No.1 – Product Status 81

The Chaeum Pure No.1 – Product Description 82

The Chaeum Pure No.2 – Product Status 82

The Chaeum Pure No.2 – Product Description 82

The Chaeum Pure No.3 – Product Status 83

The Chaeum Pure No.3 – Product Description 83

The Chaeum Pure No.4 – Product Status 83

The Chaeum Pure No.4 – Product Description 84

The Chaeum Style – Product Status 84

The Chaeum Style – Product Description 84

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 85

Wrinkle Filler – Product Status 85

Wrinkle Filler – Product Description 85

inSoma Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 86

Fractomer – Product Status 86

Fractomer – Product Description 86

Inventage Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 87

IVL-MD-B001 – Product Status 87

IVL-MD-B001 – Product Description 87

IVL-MD-F001 – Product Status 88

IVL-MD-F001 – Product Description 88

IVL-MD-F002 – Product Status 88

IVL-MD-F002 – Product Description 89

Jinwoo Bio Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

HA Filler – Product Status 90

HA Filler – Product Description 90

HA Thread Filler – Product Status 91

HA Thread Filler – Product Description 91

Wool Filler – Product Status 92

Wool Filler – Product Description 92

Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

Tenergel – Product Status 93

Tenergel – Product Description 93

Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview 94

Autologous Globin Dermal Filler – Product Status 94

Autologous Globin Dermal Filler – Product Description 94

Laboratoires Vivacy SAS Pipeline Products & Ongoing Clinical Trials Overview 95

IPN-21-SENSE Dermal Filler – Product Status 95

IPN-21-SENSE Dermal Filler – Product Description 95

Laboratoires Vivacy SAS – Ongoing Clinical Trials Overview 96

IPN-21-SENSE Dermal Filler – A Multicenter, Prospective, Randomized Controlled Clinical Study of IPN-21-SENSE, a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face 97

LG Chem Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

Dermal Filler (LR19059) – Product Status 98

Dermal Filler (LR19059) – Product Description 98

Dermal Filler (LR19093) – Product Status 99

Dermal Filler (LR19093) – Product Description 99

Hyaluronic Acid Filler (LR19094) – Product Status 99

Hyaluronic Acid Filler (LR19094) – Product Description 99

Hyaluronic Acid Filler (LR20024) – Product Status 100

Hyaluronic Acid Filler (LR20024) – Product Description 100

Next Generation Hyaluronic Acid Filler (LR20008) – Product Status 100

Next Generation Hyaluronic Acid Filler (LR20008) – Product Description 100

YVOIRE Y-Solution 360 – Product Status 101

YVOIRE Y-Solution 360 – Product Description 101

YVOIRE Y-Solution 540 – Product Status 101

YVOIRE Y-Solution 540 – Product Description 102

YVOIRE Y-Solution 720 – Product Status 102

YVOIRE Y-Solution 720 – Product Description 102

LG Chem Ltd – Ongoing Clinical Trials Overview 103

YVOIRE Y-Solution 360 – A Multicenter, Randomized, Rater-Blinded, No-Treatment Control Design Clinical Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 360 for Lip Augmentation 104

YVOIRE Y-Solution 540 – A Randomized, Multicenter, Evaluator-blinded, Active-controlled, Parallel-group Design Investigation to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 540 Versus YVOIRE Volume Plus in Nasolabial Folds Injection 105

YVOIRE Y-Solution 720 – A Multicenter, Randomized, Rater-blinded, No-treatment Control Design Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected Into the Mid-face 106

LifeSprout Inc Pipeline Products & Ongoing Clinical Trials Overview 107

Lumina – Product Status 107

Lumina – Product Description 107

LifeSprout Inc – Ongoing Clinical Trials Overview 108

Lumina – A Prospective, Randomized, Controlled, Multi-center Study of the Safety and Effectiveness of Lumina in the Treatment of Nasolabial Folds 109

Medytox Inc Pipeline Products & Ongoing Clinical Trials Overview 110

MT943 – Product Status 110

MT943 – Product Description 110

Neuramis Deep Lidocaine – Product Status 111

Neuramis Deep Lidocaine – Product Description 111

Neuramis Volume Lidocaine – Product Status 111

Neuramis Volume Lidocaine – Product Description 112

Merz North America Inc Pipeline Products & Ongoing Clinical Trials Overview 113

VP1 Lido US – Product Status 113

VP1 Lido US – Product Description 113

Merz North America Inc – Ongoing Clinical Trials Overview 114

VP1 Lido US – A Prospective, Multicenter, Randomized, Comparator-controlled, Evaluator-blinded Study to Evaluate the Safety and Effectiveness of VP1 Lido US for Volume Augmentation of the Cheek 115

Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview 116

LIFT001 – Product Status 116

LIFT001 – Product Description 116

mRDX-02-17 – Product Status 117

mRDX-02-17 – Product Description 117

Mesoestetic Pharma Group SL – Ongoing Clinical Trials Overview 118

LIFT001 – Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid 119

Moma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Restogel – 131 – Product Status 120

Restogel – 131 – Product Description 120

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 121

Ceragenin-Infused Dermal Filler – Product Status 121

Ceragenin-Infused Dermal Filler – Product Description 121

Oligo Medic Inc Pipeline Products & Ongoing Clinical Trials Overview 122

AntaRep – Product Status 122

AntaRep – Product Description 122

PB&B SA Pipeline Products & Ongoing Clinical Trials Overview 123

PB&B Facial Volumizer – Product Status 123

PB&B Facial Volumizer – Product Description 123

Peptron Inc Pipeline Products & Ongoing Clinical Trials Overview 124

PLA Dermal Filler – Product Status 124

PLA Dermal Filler – Product Description 124

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 125

CosmetaLife – Product Status 125

CosmetaLife – Product Description 125

Dermal Filler – Lip – Product Status 126

Dermal Filler – Lip – Product Description 126

Q-Med AB Pipeline Products & Ongoing Clinical Trials Overview 127

GAL1906 – Product Status 127

GAL1906 – Product Description 127

GP0112 – Product Status 128

GP0112 – Product Description 128

Q-Med AB – Ongoing Clinical Trials Overview 129

GAL1906 – A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area 130

GP0112 – A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies 131

RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 132

DermaPrecise Injector – Product Status 132

DermaPrecise Injector – Product Description 132

Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview 133

Aesthetic Filler – Product Status 133

Aesthetic Filler – Product Description 133

SYB Filler (SF-01) – Product Status 134

SYB Filler (SF-01) – Product Description 134

Sebana Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 135

Dermal Filler – Product Status 135

Dermal Filler – Product Description 135

Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 136

Organic Cross-Linked HA Dermal Filler – Product Status 136

Organic Cross-Linked HA Dermal Filler – Product Description 136

QST Gel – Product Status 137

QST Gel – Product Description 137

Shin Poong Pharm Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 138

FreeWink – Product Status 138

FreeWink – Product Description 138

Silk Medical Aesthetics Inc Pipeline Products & Ongoing Clinical Trials Overview 139

Dermal Filler – Product Status 139

Dermal Filler – Product Description 139

SMA-001 – Product Status 140

SMA-001 – Product Description 140

Silk Medical Aesthetics Inc – Ongoing Clinical Trials Overview 141

Dermal Filler – A Feasibility Clinical Trial of All-natural Dermal Filler for Nasolabial Folds 142

Sinclair Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 143

Atlean – Product Status 143

Atlean – Product Description 143

Ellanse Lidocaine – Product Status 144

Ellanse Lidocaine – Product Description 144

MaiLi – Product Status 144

MaiLi – Product Description 145

Perfectha G – Product Status 145

Perfectha G – Product Description 145

Perfectha Lips – Product Status 146

Perfectha Lips – Product Description 146

Sofregen Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 147

Silk Protein – Tissue/Dermal Filler – Product Status 147

Silk Protein – Tissue/Dermal Filler – Product Description 147

Sofregen Medical Inc – Ongoing Clinical Trials Overview 148

Silk Protein – Tissue/Dermal Filler – A Feasibility Study to Evaluate Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler 149

SunMax Biotechnology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 150

Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Status 150

Sunmax FACIALGAIN Collagen Implant With Lidocaine – Product Description 150

Sunmax FULLSGEN With Lidocaine – Product Status 151

Sunmax FULLSGEN With Lidocaine – Product Description 151

SunMax Biotechnology Co Ltd – Ongoing Clinical Trials Overview 152

Sunmax FACIALGAIN Collagen Implant With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 153

Sunmax FULLSGEN With Lidocaine – Evaluation of Collagen Dermal Filler with Lidocaine for the Correction of Nasolabial Folds: A Prospective, Randomized, Active-controlled, Double Blinded, Multicenter Clinical Trial 154

TEI Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 155

Injectable Dermal Filler – Product Status 155

Injectable Dermal Filler – Product Description 155

Tempo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 156

MAP Tissue Scaffold-Based Dermal Filler – Product Status 156

MAP Tissue Scaffold-Based Dermal Filler – Product Description 156

Teoxane SA Pipeline Products & Ongoing Clinical Trials Overview 157

Next Generation Dermal Filler – Product Status 157

Next Generation Dermal Filler – Product Description 157

Teosyal RHA 1 – Product Status 158

Teosyal RHA 1 – Product Description 158

Teoxane SA – Ongoing Clinical Trials Overview 159

Teosyal RHA 1 – A Prospective, Multicentric, Open-labelled, Interventional Study to Assess Skin Beautification by Treating Fine Lines in the Neck, Perioral and Smiling Lines Areas With TEOSYAL RHA 1 160

Teosyal RHA 1 – A Prospective, Single Blind, Single-center Study Evaluating the Histology and Intradermal Implantation of the Teosyal RHA Collection of Fillers 160

Tetratherix Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 161

Tetrafill – Product Status 161

Tetrafill – Product Description 161

Tissueform Inc Pipeline Products & Ongoing Clinical Trials Overview 162

PureVoluma – Product Status 162

PureVoluma – Product Description 162

University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview 163

Needle Free Injector – Product Status 163

Needle Free Injector – Product Description 163

University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 164

Collagen-Based Dermal Filler – Product Status 164

Collagen-Based Dermal Filler – Product Description 164

Glossary 168

Figures

Aesthetic Injectables – Pipeline Products by Stage of Development 15

Aesthetic Injectables – Pipeline Products by Segment 16

Aesthetic Injectables – Pipeline Products by Territory 17

Aesthetic Injectables – Pipeline Products by Regulatory Path 19

Aesthetic Injectables – Pipeline Products by Estimated Approval Date 20

Aesthetic Injectables – Ongoing Clinical Trials 21

Frequently asked questions

Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Aesthetic Injectables Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.